Christopher Hager

Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry

R. Greil, C. Schmitt, C. Singer, 2021, Breast Cancer Research.

Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer—results from an international, multicenter analysis coordinated by the AGMT Study Group

F. Bertucci, S. Linn, F. Puglisi, 2022, ESMO open.

Trends in use of neoadjuvant systemic therapy in patients with clinically node-positive breast cancer in Europe: prospective TAXIS study (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)

M. Gnant, V. Ostapenko, S. Loibl, 2023, Breast Cancer Research and Treatment.

Association of Axillary Dissection With Systemic Therapy in Patients With Clinically Node-Positive Breast Cancer

M. Gnant, V. Ostapenko, S. Loibl, 2023, JAMA surgery.